SCHEDULE 13G

Company

BIOCRYST PHARMACEUTICALS INC

Filed

October 26, 2000

Accession Number

0000912057-00-046045

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →